LU92263I2 - Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION) - Google Patents

Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)

Info

Publication number: LU92263I2
Authority: LU; Luxembourg
Prior art keywords: pexion; imépitoin; pharmaceutically acceptable; acceptable derivatives; alkyl
Prior art date: 1995-09-05

Application number

LU92263C

Other languages

English (en)

Original Assignee

Biocrea Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-05

Filing date

2013-08-07

Publication date

2013-10-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92263(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-08-07 Application filed by Biocrea Gmbh filed Critical Biocrea Gmbh

2013-10-07 Publication of LU92263I2 publication Critical patent/LU92263I2/fr

Links

IQHYCZKIFIHTAI-UHFFFAOYSA-N 3-(4-chlorophenyl)-5-morpholin-4-yl-4h-imidazol-2-one Chemical compound C1=CC(Cl)=CC=C1N1C(=O)N=C(N2CCOCC2)C1 IQHYCZKIFIHTAI-UHFFFAOYSA-N 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
230000002082 anti-convulsion Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
125000004404 heteroalkyl group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

LU92263C 1995-09-05 2013-08-07 Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION) LU92263I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19532668A DE19532668A1 (de)	1995-09-05	1995-09-05	Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung

Publications (1)

Publication Number	Publication Date
LU92263I2 true LU92263I2 (fr)	2013-10-07

Family

ID=7771261

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92263C LU92263I2 (fr)	1995-09-05	2013-08-07	Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)

Country Status (31)

Country	Link
EP (1)	EP0863880B1 (fr)
JP (1)	JP4030578B2 (fr)
CN (1)	CN1103762C (fr)
AR (1)	AR003502A1 (fr)
AT (1)	ATE254606T1 (fr)
AU (1)	AU700602B2 (fr)
BG (1)	BG63917B1 (fr)
BR (1)	BR9610359A (fr)
CA (1)	CA2184871C (fr)
CZ (1)	CZ291839B6 (fr)
DE (2)	DE19532668A1 (fr)
DK (1)	DK0863880T3 (fr)
EA (1)	EA000535B1 (fr)
EE (1)	EE03562B1 (fr)
ES (1)	ES2208758T3 (fr)
FR (1)	FR13C0049I2 (fr)
GE (1)	GEP20022652B (fr)
HU (1)	HU225956B1 (fr)
IL (1)	IL123333A (fr)
LT (1)	LT4482B (fr)
LU (1)	LU92263I2 (fr)
NO (1)	NO313829B1 (fr)
NZ (1)	NZ315624A (fr)
PL (1)	PL188287B1 (fr)
PT (1)	PT863880E (fr)
SK (1)	SK284868B6 (fr)
TR (1)	TR199800476T1 (fr)
TW (1)	TW422838B (fr)
UA (1)	UA46790C2 (fr)
WO (1)	WO1997009314A1 (fr)
ZA (1)	ZA967014B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19721580A1 (de) *	1997-05-23	1998-11-26	Dresden Arzneimittel	Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) *	2002-10-10	2005-03-31	Chris Rundfeldt	Use of dihydroimidazolones for the treatment of dogs
RU2354377C2 (ru) *	2003-07-11	2009-05-10	Берингер Ингельхайм Ветмедика Гмбх	Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора
EP2093218A1 (fr) *	2008-02-22	2009-08-26	Ruggero Fariello	Imidazolidinones substitués d'arylalkyl
KR20140057604A (ko)	2011-08-12	2014-05-13	베링거잉겔하임베트메디카게엠베하	고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
US9820988B2 (en)	2014-03-24	2017-11-21	Boehringer Ingelheim Vetmedica Gmbh	Treatment of epileptic disorders in feline animals
IT202100000782A1 (it)	2021-01-18	2022-07-18	Procos Spa	Processo per la sintesi di imepitoina
EP4553066A1 (fr)	2023-11-10	2025-05-14	Justesa Imagen S.A.U.	Procédé amélioré pour la synthèse d'imépitoine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE790380A (fr)	1971-10-21	1973-04-20	American Cyanamid Co	Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) *	1971-10-21	1977-08-23	American Cyanamid Company	Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) *	1975-02-07	1976-01-13	Morton-Norwich Products, Inc.	1-Arylmethyl-2-imidazolidinones

1995
- 1995-09-05 DE DE19532668A patent/DE19532668A1/de not_active Ceased
1996
- 1996-07-26 JP JP51080097A patent/JP4030578B2/ja not_active Expired - Lifetime
- 1996-07-26 PT PT96927607T patent/PT863880E/pt unknown
- 1996-07-26 IL IL12333396A patent/IL123333A/en not_active IP Right Cessation
- 1996-07-26 HU HU9802941A patent/HU225956B1/hu unknown
- 1996-07-26 AU AU67375/96A patent/AU700602B2/en not_active Expired
- 1996-07-26 WO PCT/EP1996/003295 patent/WO1997009314A1/fr not_active Ceased
- 1996-07-26 AT AT96927607T patent/ATE254606T1/de active
- 1996-07-26 DE DE59610827T patent/DE59610827D1/de not_active Expired - Lifetime
- 1996-07-26 ES ES96927607T patent/ES2208758T3/es not_active Expired - Lifetime
- 1996-07-26 EE EE9800063A patent/EE03562B1/xx unknown
- 1996-07-26 SK SK216-98A patent/SK284868B6/sk not_active IP Right Cessation
- 1996-07-26 TR TR1998/00476T patent/TR199800476T1/xx unknown
- 1996-07-26 EP EP96927607A patent/EP0863880B1/fr not_active Expired - Lifetime
- 1996-07-26 UA UA98041717A patent/UA46790C2/uk unknown
- 1996-07-26 EA EA199800271A patent/EA000535B1/ru not_active IP Right Cessation
- 1996-07-26 PL PL96325413A patent/PL188287B1/pl unknown
- 1996-07-26 CN CN96197801A patent/CN1103762C/zh not_active Expired - Lifetime
- 1996-07-26 GE GEAP19964221A patent/GEP20022652B/en unknown
- 1996-07-26 DK DK96927607T patent/DK0863880T3/da active
- 1996-07-26 CZ CZ1998661A patent/CZ291839B6/cs not_active IP Right Cessation
- 1996-07-26 NZ NZ315624A patent/NZ315624A/en not_active IP Right Cessation
- 1996-07-26 BR BR9610359A patent/BR9610359A/pt active IP Right Grant
- 1996-08-19 ZA ZA967014A patent/ZA967014B/xx unknown
- 1996-09-03 TW TW085110749A patent/TW422838B/zh not_active IP Right Cessation
- 1996-09-04 AR ARP960104226A patent/AR003502A1/es active IP Right Grant
- 1996-09-05 CA CA002184871A patent/CA2184871C/fr not_active Expired - Lifetime
1998
- 1998-02-27 BG BG102287A patent/BG63917B1/bg unknown
- 1998-03-02 NO NO19980906A patent/NO313829B1/no not_active IP Right Cessation
- 1998-04-03 LT LT98-047A patent/LT4482B/lt not_active IP Right Cessation
2013
- 2013-08-07 LU LU92263C patent/LU92263I2/fr unknown
- 2013-08-13 FR FR13C0049C patent/FR13C0049I2/fr active Active

Also Published As

Publication number	Publication date
DE59610827D1 (de)	2003-12-24
AU700602B2 (en)	1999-01-07
SK21698A3 (en)	1998-10-07
PL188287B1 (pl)	2005-01-31
CZ66198A3 (cs)	1998-07-15
DE19532668A1 (de)	1997-03-06
CZ291839B6 (cs)	2003-06-18
EA199800271A1 (ru)	1998-10-29
LT4482B (lt)	1999-03-25
IL123333A0 (en)	1998-09-24
UA46790C2 (uk)	2002-06-17
CN1200728A (zh)	1998-12-02
GEP20022652B (en)	2002-03-25
HK1015776A1 (en)	1999-10-22
HUP9802941A3 (en)	1999-10-28
IL123333A (en)	2001-10-31
PT863880E (pt)	2004-04-30
EP0863880A1 (fr)	1998-09-16
EA000535B1 (ru)	1999-10-28
NO980906L (no)	1998-03-02
AU6737596A (en)	1997-03-27
JPH11512101A (ja)	1999-10-19
ATE254606T1 (de)	2003-12-15
DK0863880T3 (da)	2004-03-22
LT98047A (en)	1998-10-26
ZA967014B (en)	1997-08-18
EE9800063A (et)	1998-08-17
CN1103762C (zh)	2003-03-26
BG63917B1 (bg)	2003-06-30
JP4030578B2 (ja)	2008-01-09
MX9801742A (es)	1998-08-30
NZ315624A (en)	1998-11-25
SK284868B6 (sk)	2006-01-05
EE03562B1 (et)	2001-12-17
WO1997009314A1 (fr)	1997-03-13
NO980906D0 (no)	1998-03-02
FR13C0049I2 (fr)	2014-03-28
PL325413A1 (en)	1998-07-20
FR13C0049I1 (fr)	2013-09-27
HU225956B1 (en)	2008-01-28
BR9610359A (pt)	1999-07-06
HUP9802941A2 (hu)	1999-09-28
CA2184871A1 (fr)	1997-03-06
CA2184871C (fr)	2001-08-21
NO313829B1 (no)	2002-12-09
BG102287A (en)	1998-09-30
TW422838B (en)	2001-02-21
ES2208758T3 (es)	2004-06-16
TR199800476T1 (xx)	1998-06-22
EP0863880B1 (fr)	2003-11-19
AR003502A1 (es)	1998-08-05

Publication	Publication Date	Title
KR100263496B1 (ko)	2002-01-09	탁솔 유도체 및 이의 제조방법
TW347387B (en)	1998-12-11	Piperidine derivatives
ZA9610315B (en)	1997-06-17	Naphthyl-substituted benzimidazole derivates as anti-coagulants
AU6613896A (en)	1996-10-30	Chemical compounds
TR199901653T2 (xx)	1999-10-21	Fitalazinonlar.
NZ313185A (en)	2000-05-26	2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
MY117092A (en)	2004-05-31	Chemotherapeutic pyrrolocarbazole derivatives
MX9602861A (es)	1997-06-28	Mezcla estabilizante sinergistica.
ATE319680T1 (de)	2006-03-15	Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen
DK0632805T3 (da)	1999-04-19	Melaminderivater til anvendelse i behandlingen af cancer
TR200001909T2 (tr)	2000-12-21	Matris metaloprotez inhibitörleri.
TR200100133T2 (tr)	2001-06-21	FKBP İnhibitörleri
DK0775113T3 (da)	2001-05-07	N-substituerede azabicycloheptan-derivater som neuroleptika osv.
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
BG102287A (en)	1998-09-30	New anticonvulsion 1-ar(alk)-imidazolin-2-ons with diasubstituted amine residue in forth place and method for their preparation
UA26459C2 (uk)	1999-08-30	Іhгібітор впливу амілоїдhих білків
TR200001122T2 (tr)	2000-08-21	Farmasötikler olarak bifenil türevleri.
ES2103675A1 (es)	1997-09-16	Nuevas piperidinas sustituidas.
TW346483B (en)	1998-12-01	Benzene derivatives
AU3350195A (en)	1996-04-09	Bicyclic carboxamides as 5-HT-1A antagonists
TR199701011A2 (xx)	1998-04-21	1-karba-(detia)-sefalosforin t�revleri.
TW358809B (en)	1999-05-21	Phenylamidinothiophene compound and anti-inflammatory agent containing the same
TW349092B (en)	1999-01-01	Substituted indole derivatives
MX9706627A (es)	1997-11-29	Derivado de tiazolidinona opticamente activo.
TW238307B (en)	1995-01-11	Novel fruo pyrazole compounds